By Thomas Kerr, CFA NASDAQ:MGRM READ THE FULL MGRM RESEARCH REPORT On March 17, 2025, Monogram (NASDAQ:MGRM) announced that the FDA has granted 510(k) clearance for its Monogram mBôs TKA System.

On February 26, 2025, Monogram (NASDAQ:MGRM) announced an update regarding its 510(k) premarket filing submission to the FDA for the company's mBôs TKA System. The company stated it had completed ...

Monogram Technologies Provides Regulatory Update on mBôs TKA System and Clinical Trial Preparation in India. Monogram Technologies Inc. Wed, Feb 26, 2025, 5:31 AM 5 min read.